Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Trevena Inc (TRVN)

Trevena Inc (TRVN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.1600 -0.1100 (-8.66%) 04/23/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 1.1600 unch (unch) 13:47 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.1600
Day High
1.2500
Open 1.2500
Previous Close 1.2700 1.2700
Volume 1,205 1,205
Avg Vol 1,410 1,410
Stochastic %K 65.50% 65.50%
Weighted Alpha -72.39 -72.39
5-Day Change +0.0500 (+4.50%) +0.0500 (+4.50%)
52-Week Range 0.9500 - 11.2450 0.9500 - 11.2450
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 1,097
  • Shares Outstanding, K 864
  • Annual Sales, $ 3,130 K
  • Annual Income, $ -40,290 K
  • EBIT $ -32 M
  • EBITDA $ -32 M
  • 60-Month Beta 1.10
  • Price/Sales 4.08
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -47.04
  • Most Recent Earnings $-5.79 on 11/07/24
  • Next Earnings Date 05/21/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -9.00
  • Growth Rate Est. (year over year) +11,200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9500 +22.11%
on 04/10/25
Period Open: 1.2800
1.4000 -17.14%
on 03/25/25
-0.1200 (-9.38%)
since 03/21/25
3-Month
0.9500 +22.11%
on 04/10/25
Period Open: 1.6900
1.9300 -39.90%
on 02/14/25
-0.5300 (-31.36%)
since 01/23/25
52-Week
0.9500 +22.11%
on 04/10/25
Period Open: 9.7000
11.2450 -89.68%
on 05/07/24
-8.5400 (-88.04%)
since 04/23/24

Most Recent Stories

More News
Trevena: Q3 Earnings Snapshot

Trevena: Q3 Earnings Snapshot

TRVN : 1.1600 (-8.66%)
Trevena Reports Third Quarter 2024 Results and Provides Business Update

TRVN : 1.1600 (-8.66%)
Trevena Announces Receipt of Nasdaq Delisting Notification

TRVN : 1.1600 (-8.66%)
Trevena: Q2 Earnings Snapshot

Trevena: Q2 Earnings Snapshot

TRVN : 1.1600 (-8.66%)
Trevena: Q1 Earnings Snapshot

Trevena: Q1 Earnings Snapshot

TRVN : 1.1600 (-8.66%)
Trevena: Q4 Earnings Snapshot

Trevena: Q4 Earnings Snapshot

TRVN : 1.1600 (-8.66%)
Trevena: Q3 Earnings Snapshot

Trevena: Q3 Earnings Snapshot

TRVN : 1.1600 (-8.66%)
Trevena: Q2 Earnings Snapshot

Trevena: Q2 Earnings Snapshot

TRVN : 1.1600 (-8.66%)
Trevena: Q1 Earnings Snapshot

Trevena: Q1 Earnings Snapshot

TRVN : 1.1600 (-8.66%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

TRVN : 1.1600 (-8.66%)
IMRN : 1.7178 (-0.71%)
IMC.AX : 0.062 (-3.13%)
LLY : 829.42 (+0.23%)
ACOR : 0.6610 (-24.86%)
SILO : 1.1601 (+3.12%)

Business Summary

Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of...

See More

Key Turning Points

3rd Resistance Point 1.2967
2nd Resistance Point 1.2833
1st Resistance Point 1.2767
Last Price 1.1600
1st Support Level 1.2567
2nd Support Level 1.2433
3rd Support Level 1.2367

See More

52-Week High 11.2450
Fibonacci 61.8% 7.3123
Fibonacci 50% 6.0975
Fibonacci 38.2% 4.8827
Last Price 1.1600
52-Week Low 0.9500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective